Related Experiment Videos
Quantitative structure-activity relationship (QSAR) study of elastase substrates and inhibitors
M Nomizu1, T Iwaki, T Yamashita
1Pharmaceutical Laboratory, Kirin Brewery Co. Ltd., Gunma, Japan.
Summary
Structure-activity relationships of peptide substrates and inhibitors were analyzed using quantitative methods. Amino acid side chain contributions were found to be additive, validating predictive models for enzyme interactions.
Area of Science:
- Biochemistry
- Enzyme kinetics
- Medicinal chemistry
Background:
- Porcine pancreatic elastase is a key enzyme in various physiological processes.
- Understanding enzyme-substrate interactions is crucial for drug design.
- Quantitative structure-activity relationships (QSAR) provide insights into molecular interactions.
Purpose of the Study:
- To synthesize and characterize peptide substrates and inhibitors for porcine pancreatic elastase.
- To quantitatively analyze the structure-activity relationships of these peptides.
- To establish a predictive model for enzyme-inhibitor interactions.
Main Methods:
- Synthesis of 100 succinyl-X-Y-aminanilide peptides and 19 trifluoroacetylated peptide inhibitors.
- Determination of kinetic parameters (Km, kcat, kcat/Km) for substrates and inhibition constants (Ki) for inhibitors.
- Quantitative analysis using the Free-Wilson/Fujita-Ban method and free-energy-related substituent constants.
Main Results:
- The contributions of amino acid side chains to kinetic constants (Km, kcat, kcat/Km) were found to be additive.
- A strong correlation was observed between inhibitor constants (Ki) and substrate Michaelis constants (Km).
- The equation log(1/Ki) = 1.271 log(1/Km) + 4.831 was validated, confirming the predictive model.
Conclusions:
- The additive nature of amino acid side chain contributions simplifies the prediction of enzyme-substrate and enzyme-inhibitor interactions.
- This study provides a foundational approach for unraveling structure-activity relationships in peptide-based therapeutics and agrochemicals.
- The validated quantitative model can guide the rational design of novel enzyme inhibitors and substrates.